-
AY 9944 dihydrochloride: Reliable DHCR7 Assays
2026-09-10
A scenario-based guide to using AY 9944 dihydrochloride (SKU A8658) for reproducible DHCR7 inhibition, sterol profiling, membrane-raft studies, and PBMC immune assays. It separates product-supported parameters from experimental recommendations and clarifies how chemical inhibition should be interpreted alongside genetic evidence.
-
NIH/3T3 Cells: Recovery, Culture, and QC
2026-09-10
NIH/3T3 Cells provide an adherent mouse fibroblast model for routine culture, cell transfection studies, viral proliferation research, and oncogene research. This guide explains recovery, expansion, assay preparation, and quality control while limiting interpretation to the product dossier and established workflow practice rather than unsupported quantitative or clinical conclusions.
-
TNF-alpha Recombinant Murine Protein in Apoptosis Assays
2026-09-09
Use TNF-alpha recombinant murine protein as a defined receptor-driven apoptosis stimulus, an inflammation model component, or an orthogonal comparator for transcription-inhibition studies. Its strong L929 cytotoxicity benchmark and controlled recombinant format support dose finding, pathway separation, and reproducible cell culture cytokine treatment.
-
n-Dodecyl-β-D-maltoside for Reliable Assays
2026-09-09
Learn how n-Dodecyl-β-D-maltoside (SKU C4421) can support membrane-protein preparation while helping researchers control detergent-related variability in viability, proliferation, and cytotoxicity workflows. This scenario-based guide covers compatibility, optimization, interpretation, and practical vendor selection.
-
Anti-ROR1 Antibody: Applied Workflows
2026-09-08
Anti-ROR1 Antibody (Zilovertamab) combines receptor-specific binding with functional blockade for ROR1 pathway studies, making it useful across ELISA, FACS, signaling assays, and carefully qualified model systems. This guide translates the product’s specifications and a DON hepatotoxicity study into practical assay design, controls, and troubleshooting decisions.
-
EZ Cap™ Firefly Luciferase mRNA Workflow
2026-09-08
Use EZ Cap™ Firefly Luciferase mRNA to separate delivery, translation, and reporter-performance questions in cell-based assays and in vivo imaging. Its Cap1 structure and optimized poly(A) tail support sustained signal, while a recent LNP study shows why functional potency—not particle quality alone—should guide formulation decisions.
-
IEM-1925 Against Soman-Induced Status Epilepticus
2026-09-07
A 2026 NeuroToxicology study evaluated IEM-1925 after soman exposure in rats and found combined antiseizure, neuroprotective, and cognitive benefits. By pairing EEG, neuropathology, and behavioral testing, the work supports dual AMPA/NMDA glutamate-receptor targeting as a strategy for limiting both acute status epilepticus and later neurological injury.
-
Recombinant Human Oncostatin M in Fibrosis Assays
2026-09-05
Recombinant Human Oncostatin M provides a controlled cytokine perturbation for dissecting inflammatory crosstalk, cell proliferation, and cytokine-release phenotypes. This article translates mast cell–mesothelial fibrosis findings into a causally resolved assay strategy while defining the evidence limits of OSM-based models.
-
KU-60019: Reframing ATM Inhibition in Glioma
2026-09-05
ATM inhibition is more than a DNA damage response strategy. In glioma models, KU-60019 provides a selective pharmacological entry point for studying radiosensitization, prosurvival signaling, invasion, and the metabolic adaptation that may allow ATM-inhibited tumors to persist under nutrient stress.
-
CH 223191: From AhR Blockade to Causal Biology
2026-09-04
How CH 223191 converts AhR activation from a descriptive signal into a testable mechanism across ovarian toxicology, dioxin biology, and translational assay design.
-
Dimetridazole Workflows for Antimicrobial Research
2026-09-04
Dimetridazole supports parallel antimicrobial, antivirulence, biofilm, combination-screening, and electrochemical workflows. This guide shows how to separate growth inhibition from quorum-sensing effects and adapt a highly sensitive molecularly imprinted sensor strategy for reproducible assay development.
-
Forsythoside E: PKM2 Inhibitor Workflow
2026-09-03
Forsythoside E is a mechanism-led tool for connecting PKM2 tetramerization, macrophage metabolic remodeling, and M2 polarization. This practical guide shows how to build dose-response, signaling, transcriptomic, binding, and sepsis-induced liver injury workflows while separating established product data from assay recommendations.
-
Sulfo-Cy5 NHS Ester for Reliable Cell Assays
2026-09-03
This scenario-based guide explains how Sulfo-Cy5 NHS ester, SKU A8108, supports aqueous protein labeling, far-red cellular imaging, and more interpretable viability or cytotoxicity workflows. It connects reagent selection, protocol controls, spectral performance, storage, and vendor reliability to practical laboratory decisions.
-
PtrbZIP12 Controls Poplar Drought Resistance
2026-09-02
The reference study identifies PtrbZIP12 as a positive regulator of drought tolerance in Populus trichocarpa and links its activity directly to the PtrDHN and PtrPOD stress-response genes. By combining genetic perturbation, transcriptomics, promoter-binding assays, and transactivation tests, the work also highlights phosphorylation as an important modifier of PtrbZIP12-mediated transcription.
-
Phosphatase Inhibitor Cocktail 3 (100X in DMSO)
2026-09-02
Phosphatase Inhibitor Cocktail 3 (100X in DMSO) helps limit dephosphorylation during protein extraction, supporting preservation of phosphorylation states for Western blotting, immunoprecipitation, and related phosphoprotein analyses. It is intended for lysates and phosphorylation-dependent workflows, but should be compatibility-tested when DMSO or phosphatase inhibition could interfere with the assay.